RATIONALE: The lifetime risk of tuberculosis (TB) for infected contacts is often mentioned to be 5-10%, but these estimates are based on studies conducted decades ago, and thus may not reflect current epidemiologic conditions. OBJECTIVES: To estimate the risk of TB among contacts with evidence of infection and to compare this with estimates often stated in the literature. METHODS: A retrospective cohort study was performed using records on contacts of pulmonary TB patients at the Public Health Service Amsterdam, 2002-2011. The Public Health Service Amsterdam TB electronic registration system identified TB cases during follow-up until October 2012; these were defined as coprevalent if diagnosed less than or equal to 180 days and incident if diagnosed greater than 180 days after TB diagnosis of index patient. Cumulative TB risk was estimated with Kaplan-Meier curves. MEASUREMENTS AND MAIN RESULTS: Of 9,332 contacts of pulmonary TB patients, 4,774 were screened for latent TB infection (LTBI) of whom 739 (16%) had evidence of infection. Among these the 5-year Kaplan-Meier TB cumulative risk was 9.5% (95% confidence interval, 7.5-11.9). This varied by age: 33.3% of 36 contacts aged less than 5 years, 19.1% of 84 contacts aged 5-14 years, and 6.7% of 619 contacts aged greater than or equal to 15 years (log rank, P < 0.001). Of 739 contacts with evidence of infection, 57 had coprevalent TB and 14 developed incident TB. Of patients without coprevalent TB but with LTBI diagnosis, 45% received preventive therapy. Five-year risk of incident TB was 2.4% (95% confidence interval, 1.2-4.7) among contacts with LTBI who did not start preventive therapy. CONCLUSIONS: Five-year risk of TB among contacts with evidence of infection was higher compared with older estimates, and differed considerably by age. Incidence of TB among contacts with LTBI was low, suggesting limited impact may be expected of expanding preventive therapy.
RATIONALE: The lifetime risk of tuberculosis (TB) for infected contacts is often mentioned to be 5-10%, but these estimates are based on studies conducted decades ago, and thus may not reflect current epidemiologic conditions. OBJECTIVES: To estimate the risk of TB among contacts with evidence of infection and to compare this with estimates often stated in the literature. METHODS: A retrospective cohort study was performed using records on contacts of pulmonary TBpatients at the Public Health Service Amsterdam, 2002-2011. The Public Health Service Amsterdam TB electronic registration system identified TB cases during follow-up until October 2012; these were defined as coprevalent if diagnosed less than or equal to 180 days and incident if diagnosed greater than 180 days after TB diagnosis of index patient. Cumulative TB risk was estimated with Kaplan-Meier curves. MEASUREMENTS AND MAIN RESULTS: Of 9,332 contacts of pulmonary TBpatients, 4,774 were screened for latent TB infection (LTBI) of whom 739 (16%) had evidence of infection. Among these the 5-year Kaplan-Meier TB cumulative risk was 9.5% (95% confidence interval, 7.5-11.9). This varied by age: 33.3% of 36 contacts aged less than 5 years, 19.1% of 84 contacts aged 5-14 years, and 6.7% of 619 contacts aged greater than or equal to 15 years (log rank, P < 0.001). Of 739 contacts with evidence of infection, 57 had coprevalent TB and 14 developed incident TB. Of patients without coprevalent TB but with LTBI diagnosis, 45% received preventive therapy. Five-year risk of incident TB was 2.4% (95% confidence interval, 1.2-4.7) among contacts with LTBI who did not start preventive therapy. CONCLUSIONS: Five-year risk of TB among contacts with evidence of infection was higher compared with older estimates, and differed considerably by age. Incidence of TB among contacts with LTBI was low, suggesting limited impact may be expected of expanding preventive therapy.
Authors: Catherine M Stein; Sarah Zalwango; LaShaunda L Malone; Bonnie Thiel; Ezekiel Mupere; Mary Nsereko; Brenda Okware; Hussein Kisingo; Christina L Lancioni; Charles M Bark; Christopher C Whalen; Moses L Joloba; W Henry Boom; Harriet Mayanja-Kizza Journal: Am J Epidemiol Date: 2018-07-01 Impact factor: 4.897
Authors: Anna M Mandalakas; H Lester Kirchner; Gerhard Walzl; Robert P Gie; H Simon Schaaf; Mark F Cotton; Harleen M S Grewal; Anneke C Hesseling Journal: Am J Respir Crit Care Med Date: 2015-04-01 Impact factor: 21.405
Authors: Mary R Reichler; Awal Khan; Timothy R Sterling; Hui Zhao; Bin Chen; Yan Yuan; Joyce Moran; James McAuley; Bonita Mangura Journal: Clin Infect Dis Date: 2020-04-10 Impact factor: 9.079
Authors: Marc Lipman; Mahdad Noursadeghi; Ibrahim Abubakar; Rishi K Gupta; Claire J Calderwood; Alexei Yavlinsky; Maria Krutikov; Matteo Quartagno; Maximilian C Aichelburg; Neus Altet; Roland Diel; Claudia C Dobler; Jose Dominguez; Joseph S Doyle; Connie Erkens; Steffen Geis; Pranabashis Haldar; Anja M Hauri; Thomas Hermansen; James C Johnston; Christoph Lange; Berit Lange; Frank van Leth; Laura Muñoz; Christine Roder; Kamila Romanowski; David Roth; Martina Sester; Rosa Sloot; Giovanni Sotgiu; Gerrit Woltmann; Takashi Yoshiyama; Jean-Pierre Zellweger; Dominik Zenner; Robert W Aldridge; Andrew Copas; Molebogeng X Rangaka Journal: Nat Med Date: 2020-10-19 Impact factor: 53.440
Authors: Yicheng Ma; Helen E Jenkins; Paola Sebastiani; Jerrold J Ellner; Edward C Jones-López; Reynaldo Dietze; Charles R Horsburgh; Laura F White Journal: Am J Epidemiol Date: 2020-11-02 Impact factor: 4.897
Authors: Aditya Sharma; Andrew Hill; Ekaterina Kurbatova; Martie van der Walt; Charlotte Kvasnovsky; Thelma E Tupasi; Janice C Caoili; Maria Tarcela Gler; Grigory V Volchenkov; Boris Y Kazennyy; Olga V Demikhova; Jaime Bayona; Carmen Contreras; Martin Yagui; Vaira Leimane; Sang Nae Cho; Hee Jin Kim; Kai Kliiman; Somsak Akksilp; Ruwen Jou; Julia Ershova; Tracy Dalton; Peter Cegielski Journal: Lancet Infect Dis Date: 2017-05-09 Impact factor: 25.071
Authors: Edward C Jones-López; Carlos Acuña-Villaorduña; Martin Ssebidandi; Mary Gaeddert; Rachel W Kubiak; Irene Ayakaka; Laura F White; Moses Joloba; Alphonse Okwera; Kevin P Fennelly Journal: Clin Infect Dis Date: 2016-03-29 Impact factor: 9.079